关注
Feiyu Chen
Feiyu Chen
未知所在单位机构
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula zuojin pill in suppressing hepatocellular carcinoma
W Guo, J Huang, N Wang, HY Tan, F Cheung, F Chen, Y Feng
Frontiers in Pharmacology 10, 1185, 2019
1772019
Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application
Y Xu, W Guo, C Zhang, F Chen, HY Tan, S Li, N Wang, Y Feng
Frontiers in Pharmacology 11, 601, 2020
1042020
microRNA-23a in human cancer: its roles, mechanisms and therapeutic relevance
N Wang, HY Tan, YG Feng, C Zhang, F Chen, Y Feng
Cancers 11 (1), 7, 2018
872018
Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF‐1α‐independent VEGF expression and angiogenesis in hepatocellular carcinoma
C Zhang, N Wang, HY Tan, W Guo, F Chen, Z Zhong, K Man, SW Tsao, ...
British Journal of Pharmacology 177 (14), 3240-3257, 2020
572020
Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
Z Zhong, CT Vong, F Chen, H Tan, C Zhang, N Wang, L Cui, Y Wang, ...
Medicinal Research Reviews 42 (3), 1246-1279, 2022
562022
Targeting cancer metabolism to resensitize chemotherapy: potential development of cancer chemosensitizers from traditional Chinese medicines
W Guo, HY Tan, F Chen, N Wang, Y Feng
Cancers 12 (2), 404, 2020
502020
The impacts of herbal medicines and natural products on regulating the hepatic lipid metabolism
S Li, Y Xu, W Guo, F Chen, C Zhang, HY Tan, N Wang, Y Feng
Frontiers in Pharmacology 11, 351, 2020
482020
Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3p
F Chen, Z Zhong, HY Tan, W Guo, C Zhang, CS Cheng, N Wang, J Ren, ...
Clinical and translational medicine 10 (6), e190, 2020
472020
The functional roles of exosomes-derived long non-coding RNA in human cancer
F Chen, N Wang, HY Tan, W Guo, C Zhang, Y Feng
Cancer Biology & Therapy 20 (5), 583-592, 2019
452019
PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma
N Wang, HY Tan, Y Lu, YT Chan, D Wang, W Guo, Y Xu, C Zhang, F Chen, ...
Signal Transduction and Targeted Therapy 6 (1), 86, 2021
382021
Interpreting the pharmacological mechanisms of huachansu capsules on hepatocellular carcinoma through combining network pharmacology and experimental evaluation
J Huang, F Chen, Z Zhong, HY Tan, N Wang, Y Liu, X Fang, T Yang, ...
Frontiers in Pharmacology 11, 414, 2020
382020
ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis
HY Tan, N Wang, YT Chan, C Zhang, W Guo, F Chen, Z Zhong, S Li, ...
Cancer Letters 475, 109-118, 2020
272020
The Significance of circulating tumor cells in patients with hepatocellular carcinoma: real-time monitoring and moving targets for cancer therapy
F Chen, Z Zhong, HY Tan, N Wang, Y Feng
Cancers 12 (7), 1734, 2020
232020
Uncovering the anticancer mechanisms of Chinese herbal medicine formulas: Therapeutic alternatives for liver cancer
F Chen, Z Zhong, HY Tan, W Guo, C Zhang, C Tan, S Li, N Wang, Y Feng
Frontiers in Pharmacology 11, 293, 2020
222020
Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies
W Shi, Y Wang, Y Zhao, JJ Kim, H Li, C Meng, F Chen, J Zhang, DH Mak, ...
Science translational medicine 15 (695), eadf6724, 2023
142023
The Underlying Mechanisms of Chinese Herbal Medicine-Induced Apoptotic Cell Death in Human Cancer
F Chen, Z Zhong, HY Tan, N Wang, Y Feng
Programmed Cell Death, 3, 2020
22020
Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine
F Chen, Z Zhong, C Zhang, Y Lu, YT Chan, N Wang, D Zhao, Y Feng
International journal of molecular sciences 23 (21), 13334, 2022
12022
What Chinese Medicine Can Do for Liver Cancer?
F Chen, N Wang, Y Feng
Liver Cancer, 2018
12018
系统目前无法执行此操作,请稍后再试。
文章 1–18